Pleomorphic Xanthoastrocytoma Completed Phase 2 Trials for Vincristine (DB00541)

Also known as: Pleomorphic Xanthoastrocytoma of Brain / Pleomorphic Xantho-Astrocytoma / Pleomorphic Xanthoastrocytomas / Pleomorphic xanthoastrocytoma (morphologic abnormality) / Pleomorphic xanthoastrocytoma of brain (disorder) / Astrocytoma, Grade II / Diffuse astrocytoma (morphologic abnormality) / Astrocytoma low grade (morphologic abnormality) / Astrocytoma, low grade

IndicationStatusPhase
DBCOND0062672 (Pleomorphic Xanthoastrocytoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02684058Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsTreatment